Experienced Retirement Experts Josh Forstater and Tina Anstett Join the FirmNEW YORK, Jan. 6, 2025 /PRNewswire/ -- J.P. Morgan Asset Management today announced that Josh Forstater and Tina Anstett have joined the firm in key leadership positions on the Retirement team. These strategic hires reflect J.P. Morgan Asset Management's dedication to providing innovative solutions and insights to support the evolving needs of retirement plan sponsors, advisors, consultants, and participants. Josh Forstater Tina ...

The first earnings season of the New Year will get underway on January 10th, with the big banks reporting results for the last quarter of 2024.The expectation is that 2024 Q4 earnings for the S&P 500 index will be up +7.6% on +4.7% higher revenues. This would follow the +8.3% earnings growth in Q3 on +5.5% higher revenues.As we have noted here all along, the revisions trend ahead of the start of the Q4 earnings season has been fairly stable, as can be seen in the chart below that shows how the Q4 earnings g ...

JPMorgan Chase & Co. (JPM) closed at $238.39 in the latest trading session, marking a +0.33% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.73% for the day. On the other hand, the Dow registered a gain of 0.16%, and the technology-centric Nasdaq increased by 0.98%.The the stock of company has fallen by 4.41% in the past month, lagging the Finance sector's loss of 2.93% and the S&P 500's gain of 0.34%.Market participants will be closely following the financial resu ...

The U.S. Consumer Financial Protection Bureau (“CFPB”) filed a lawsuit on Friday against JPMorgan (JPM) , Bank of America Corp. (BAC) and Wells Fargo & Co. (WFC) for failing to protect consumers from widespread fraud on Zelle, the renowned payments network. The lawsuit also targets Early Warning Services LLC, Zelle’s official operator.Details of the LawsuitLaunched in 2017, the Zelle network aimed to be the go-to alternative to money transfer giants like Venmo and Cash App. It is owned by seven major banks, ...

Believe it or not, there are now nine publicly traded U.S. companies worth $1 trillion or more.They are Apple, Microsoft, Nvidia, Amazon, Alphabet, Meta Platforms, Tesla, Broadcom, and Taiwan Semiconductor. Berkshire Hathaway was briefly a member of the group, but its market cap has dipped slightly below the threshold this month. Still, it seems likely that it will rise back above the mark again, effectively making the conglomerate the tenth trillion-dollar company.Just a few years ago, there weren't any U. ...

On Wednesday, the Federal Reserve signaled that the pace of interest rate cuts will slow down significantly in 2025. As such, investors turned bearish, and rate-sensitive stocks, including JPMorgan (JPM) , plunged. However, the stock rebounded thereafter with a year-to-date return of 36.9%.JPM shares have outperformed not only the S&P 500 Index but also its industry peers – Bank of America (BAC) and Citigroup (C) this year.Year-to-Date Price Performance Image Source: Zacks Investment ResearchFewer Interest ...

Retail traders are constantly exposed to so many indicators that their screens often become convoluted with different studies and graphics, blurring out what is really happening. However, all indicators come from one single source: the price action of a stock or any other instrument, so understanding the source is key before anything else. However, price action alone will not give investors much of an answer, at least by itself. When analyzing the price action of a stock or exchange-traded fund (ETF), the i ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about JPMorgan Chase & Co. (JPM) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.JPMorgan Chase & Co. c ...

ZyVersa is advancing a pipeline of first-in-class drug candidates built around two proprietary technologies. - Inflammasome ASC Inhibitor IC 100 designed to attenuate initiation and perpetuation of disease-causing inflammation; lead indication: obesity with metabolic complications (e.g., cardiovascular disease). - Cholesterol Efflux Mediator™ VAR 200 designed to mediate removal of renal lipids and cholesterol that lead to kidney damage and disease; phase 2a clinical trial in diabetic kidney disease expected ...

JPMorgan Chase & Co. (JPM) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earning ...